Conference
114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC)
Authors
Peled N; Rodriguez-Abreu D; Bordoni R; Ellis PM; Hochmair M; Müller V; Levchenko E; Zhou H; Zhao B; Lara-Guerra H
Volume
32
Publisher
Elsevier
Publication Date
December 1, 2021
DOI
10.1016/j.annonc.2021.10.132
Conference proceedings
Annals of Oncology
ISSN
0923-7534